Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.

Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.

Item
http://www.wikidata.org/entity/Q38865504
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.A New Methodology for Incorporating Chiral Linkers into Stapled Peptides.Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
P2860

Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.

Item
http://www.wikidata.org/entity/Q38865504
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
@en
type
label
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
@en
prefLabel
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698